Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I:  a case report

IWAMOTO J; MATSU K; TAKEDA T; ICHIMURA S; UZAWA M

Art

J-GLOBAL ID：200902232468697009 Reference number：03A0270494

Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report

骨形成不全症タイプIのエチドロナートやアルファカルシドールでの治療効果 1症例報告

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=03A0270494&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=03A0270494&from=J-GLOBAL&jstjournalNo=L3245A") }}

Author (5)： , , , ,
Material：
Volume： 8 Issue： 2 Page： 243-247 Publication year： 2003
JST Material Number： L3245A ISSN： 0949-2658 CODEN： JOSCFS Document type： Article
Article type：短報 Country of issue： Netherlands (NLD) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=03A0270494&from=J-GLOBAL&jstjournalNo=L3245A") }}

Drug therapy(=pharmacotherapy)for musculoskeletal diseases , Clinical application of other drugs acting on metabolism

Reference (25)：

ALBRIGHT, JA. Studies of patients with osteogenesis imperfecta. J Bone Joint Surg Am. 1971, 53, 1415-1425
ASTROM, E. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child. 2002, 86, 356-364
BARON, R. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res. 1983, 17, 204-207
FAIRNEY, A. Response to alendronate in osteoporosis after previous treatment with etidronate. Osteoporos Int. 2000, 11, 621-625
FUJITA, T. Double-blind multicenter comparative study with alfacalidol of etidronate dissdium (EHDP) in involutional osteoporosis. Clin Eval. 1993, 21, 261-302

ｍore...

, , , , ,

Return to Previous Page